IP Library Granted Patent US 9,474,814
Granted Patent B2
US 9,474,814 · App. 13/952,536 · Granted Oct 25, 2016

Differential evaporation potentiated disinfectant system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,474,814
App. No.
13/952,536
Granted
Oct 25, 2016
Kind
B2
Abstract

Antimicrobial compositions and methods of using such antimicrobial compositions to provide a reduction in populations of viable microorganisms.

Claims (11)

1. A method of reducing a population of microorganisms capable of reproduction, comprising:

obtaining a differential evaporation potentiated antimicrobial composition including an antimicrobially active agent and water, said antimicrobially active agent miscible in said water, said antimicrobially active agent having an initial concentration of between about 5 percent to about 10 percent by volume, said antimicrobially active agent consisting essentially of ethylene glycol monobutyl ether; and

contacting said population of microorganisms capable of reproduction with said differential evaporation potentiated antimicrobial composition, said differential evaporation potentiated antimicrobial composition having a concentration of said antimicrobially active agent which increases during a period of time in which said water evaporates from said composition resulting in a concentration of said antimicrobially active agent which provides greater than a 2-log 10 order reduction in said population of microorganisms capable of reproduction.

2. The method of claim 1 , further comprising reducing said population of microorganisms capable of reproduction by greater than said 2-log 10 order within a period of time after contacting said population of microorganisms capable of reproduction with said differential evaporation potentiated antimicrobial composition of not greater than thirty minutes.

3. The method of claim 2 , further comprising contacting said population of microorganisms capable of reproduction while contained in an amount of diluent miscible in said antimicrobial composition.

4. The method of claim 3 , wherein said population of microorganisms capable of reproduction is selected from the group consisting of: Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Aspergillus niger , and Clostridium sporogenes.

5. The method of claim 1 , further comprising:

evaporating said water from said differential evaporation potentiated antimicrobial composition to generate an azeotrope of said antimicrobially active agent combined with said water.

6. The method of claim 5 , wherein combining said antimicrobially active agent with said water occurs within a temperature range of about 5° C. and about 90° C. at 760 mm Hg.

7. The method of claim 6 , wherein evaporating occurs within said temperature range of between about 5° C. and about 90° C. at 760 mm Hg.

8. The method of claim 7 , wherein evaporating leaves no residue.

Assignments (4)
SECURITY INTEREST Recorded Nov 24, 2025
From: XY, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 073020/0041 →
SECURITY INTEREST Recorded Mar 31, 2021
From: XY, LLC
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055791/0548 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2016
From: CHD BIOSCIENCE, INC.
To: XY, LLC
Reel/Frame 039780/0419 →
SECURITY INTEREST Recorded Mar 24, 2015
From: XY, LLC
To: COMPASS BANK
Reel/Frame 035241/0944 →